- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Alto Neuroscience Inc (ANRO)
Alto Neuroscience Inc stock price live, this page displays NYSE ANRO stock exchange data. View the ANRO premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Alto Neuroscience Inc real time stock price chart below.
What Is the Alto Neuroscience Inc Stock Price Today?
The Alto Neuroscience Inc stock price today is 5.56.
What Is the Stock Symbol for Alto Neuroscience Inc?
The stock symbol for Alto Neuroscience Inc is ""ANRO.""
What Stock Exchange Does Alto Neuroscience Inc Trade On?
Alto Neuroscience Inc is listed and trades on the NYSE stock exchange.
Is Alto Neuroscience Inc a Good Stock to Buy?
Determining whether Alto Neuroscience Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ANRO quote. (ISIN: US02157Q1094)
What Is the Alto Neuroscience Inc Stock Price Today?
The Alto Neuroscience Inc stock price today is 5.56.
What Is the Stock Symbol for Alto Neuroscience Inc?
The stock symbol for Alto Neuroscience Inc is ""ANRO.""
What Stock Exchange Does Alto Neuroscience Inc Trade On?
Alto Neuroscience Inc is listed and trades on the NYSE stock exchange.
Is Alto Neuroscience Inc a Good Stock to Buy?
Determining whether Alto Neuroscience Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ANRO quote. (ISIN: US02157Q1094)
NYSE
Currency in USD
5.56
-0.33(-5.53%)
Real-time Data·
Fair Value
An estimate of a Alto Neuroscience's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.23
5.78
52 wk Range
1.60
15.04
ANRO is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Alto Neuroscience's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.235.78
52 wk Range
1.6015.04
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Strong Sell
Moving Averages
Neutral
ANRO Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Alto Neuroscience's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Strong Buy
Price Target
11.00
Upside
+97.84%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
- Alto Neuroscience receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Alto Neuroscience receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Alto Neuroscience Inc Company Profile
Alto Neuroscience, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company’s product pipeline includes ALTO-100, which is in Phase 2b clinical trial for the treatment of patients with bipolar depression (BPD). It also develops ALTO-300, a small molecule melatonergic agonist and serotonergic antagonist with antidepressant properties, which is in Phase 2b clinical trial to treat patients with major depressive disorder (MDD); ALTO-101, a novel small molecule phosphodiesterase 4 inhibitor that is in Phase 2 proof-of-concept (POC) trial for the treatment of cognitive impairment associated with schizophrenia; ALTO-203, a novel small-molecule histamine H3 receptor inverse agonist, which is in Phase 2 POC trial to treat patients with MDD and higher levels of anhedonia; and ALTO-202, an investigational orally bioavailable antagonist of the GluN2B subunit of the NMDA receptor that is in Phase 1 clinical trial for the treatment of MDD. The company was incorporated in 2019 and is headquartered in Mountain View, California.
Compare ANRO to Peers and Sector
Metrics to compare | ANRO | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipANROPeersSector | |
|---|---|---|---|---|
P/E Ratio | −2.3x | −1.7x | −0.7x | |
PEG Ratio | −0.07 | 0.14 | 0.00 | |
Price/Book | 1.2x | 3.6x | 2.6x | |
Price / LTM Sales | - | 1.6x | 3.4x | |
Upside (Analyst Target) | 70.1% | 148.4% | 37.8% | |
Fair Value Upside | Unlock | 16.0% | 5.5% | Unlock |
Analyst Ratings
8 Buy
1 Hold
0 Sell
Ratings:
9 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 11.00
(+97.84% Upside)
Earnings
Latest Release
Aug 13, 2025
EPS / Forecast
-0.65 / -0.60
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Stock Exchange Does Alto Neuroscience Trade On?
Alto Neuroscience is listed and trades on the New York Stock Exchange stock exchange.
What Is the Stock Symbol for Alto Neuroscience?
The stock symbol for Alto Neuroscience is "ANRO."
What Is the Alto Neuroscience Market Cap?
As of today, Alto Neuroscience market cap is 159.21M.
What Is Alto Neuroscience's Earnings Per Share (TTM)?
The Alto Neuroscience EPS (TTM) is -2.40.
When Is the Next Alto Neuroscience Earnings Date?
Alto Neuroscience will release its next earnings report on 17 Nov 2025.
From a Technical Analysis Perspective, Is ANRO a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Alto Neuroscience Stock Split?
Alto Neuroscience has split 0 times.
How Many Employees Does Alto Neuroscience Have?
Alto Neuroscience has 0 employees.
What is the current trading status of Alto Neuroscience (ANRO)?
As of 14 Oct 2025, Alto Neuroscience (ANRO) is trading at a price of 5.56, with a previous close of 5.88. The stock has fluctuated within a day range of 5.23 to 5.78, while its 52-week range spans from 1.60 to 15.04.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.